Sampurna Chatterjee

机构：Massachusetts General Hospital, AstraZeneca (United States) · ORCID：0000-0003-0850-0328

发表论文 65 篇 · 总被引 1470 次 · h-index 15

代表论文

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages (2016 · Proceedings of the National Academy of Sciences · 被引 322)
Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy (2021 · Proceedings of the National Academy of Sciences · 被引 97)
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin (2020 · Nature Biomedical Engineering · 被引 72)
Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes (2023 · The Journal of Experimental Medicine · 被引 68)
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models (2023 · Proceedings of the National Academy of Sciences · 被引 63)
Transient Antiangiogenic Treatment Improves Delivery of Cytotoxic Compounds and Therapeutic Outcome in Lung Cancer (2014 · Cancer Research · 被引 35)